Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
about
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
@en
Phase II Study of Isoflavone G-2535
@nl
type
label
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
@en
Phase II Study of Isoflavone G-2535
@nl
prefLabel
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
@en
Phase II Study of Isoflavone G-2535
@nl
P1476
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
@en
P3098
NCT00118040
P4844
P580
2005-06-01T00:00:00Z
P582
2010-08-01T00:00:00Z